JF
ACET icon

Jump Financial’s Adicet Bio ACET Stock Holding History

Jump Financial’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,721
Closed -$145K – 1791
2023
Q2 		$145K Buy
3,721
+1,140
+44% +$101K 0.01% 1589
2023
Q1 		$238K Buy
+2,581
New +$324K 0.01% 1234
2022
Q3 		– Sell
-731
Closed -$171K – 1525
2022
Q2 		$171K Sell
731
-732
-50% -$161K 0.01% 1345
2022
Q1 		$467K Sell
1,463
-768
-34% -$177K 0.02% 846
2021
Q4 		$624K Buy
+2,231
New +$383K 0.04% 560
2021
Q3 		– Sell
-831
Closed -$137K – 1054
2021
Q2 		$137K Buy
+831
New +$169K 0.01% 942

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Jump Financial's ACET Position: Q3 2023 in Review

Jump Financial sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 3,721 shares — an estimated $145K sold.

Jump Financial first reported a position in ACET in Q2 2021 and held it in 6 quarters. The position peaked at $624K in Q4 2021. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Jump Financial reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Jump Financial sold 3,721 Adicet Bio shares in Q3 2023, an estimated $145K.
  • Jump Financial first reported a position in Adicet Bio in Q2 2021 and held it in 6 quarters.
  • Jump Financial's Adicet Bio position peaked at $624K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Jump Financial's 13F filing for Q3 2023, filed 7 Nov 2023.